Angiotech Sells Interventional Business To Argon Medical Devices
This article was originally published in The Gray Sheet
Executive Summary
The deal will allow Angiotech to pay off all of its debt obligations and will bring the interventional products business, which includes biopsy devices and drainage catheters, back to its former owners.